8 September 2026
Structure oral GLP-1 shows 16.2% loss without a plateau
The 180-mg aleniglipron dose reached that figure at 72 weeks in the company’s press release.
The full briefing is in the app.
8 September 2026
The 180-mg aleniglipron dose reached that figure at 72 weeks in the company’s press release.
The full briefing is in the app.